NCT04406844 is a clinical trial in Oncology Patients, sponsored by Max Healthcare Insititute Limited.

Who is sponsoring NCT04406844?

NCT04406844 is sponsored by Max Healthcare Insititute Limited.

What condition does NCT04406844 study?

NCT04406844 studies Oncology Patients.

Is NCT04406844 still recruiting?

NCT04406844 is currently status unknown. Last updated 22 July 2020.

Last reviewed 2020-07-22 · How we verify

NCT04406844

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic

Status unknown Last updated 22 July 2020

What this trial tests

trial in Oncology Patients in 150 participants. Status unknown.

Timeline

9 May 2020

Primary endpoint
30 June 2021

30 June 2021

Quick facts

Lead sponsor	Max Healthcare Insititute Limited
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	150
Start date	9 May 2020
Primary completion	30 June 2021
Estimated completion	30 June 2021
Sites	1 location across India

Conditions studied

Oncology Patients — all drugs for Oncology Patients →

Sponsor

Max Healthcare Insititute Limited

Who can join

Adults 12 to 98, any sex, with Oncology Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In view of increasing cases of SARS-CoV-2 leading to the COVID-19 Pandemic in India,there has been unprecedented restrictions on travel, work and other aspects of daily life. Our study has been designed to collect data of cancer patients to analyze their issues and challenges during Covid-19 Pandemic.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial?
Vivarelli S, Falzone L, Grillo CM, Scandurra G, et al · · 2020 · cited 63× · PMID 32785162 · DOI 10.3390/cancers12082237

Verify or expand the search:

Other recruiting trials for Oncology Patients

Currently open trials in the same condition.

NCT07443839 — Oncology Legal Navigation Study · NA · recruiting

Other Max Healthcare Insititute Limited trials

Trials by the same sponsor.

NCT07496333 — The Effect of Virtual Reality Distraction on Pain During Colonoscopy · NA · completed
NCT06456216 — Performance Evaluation of Diagnostic Accuracy of PanTum Detect Test for Detection of Solid Tumours in Known Cancer Popul · completed
NCT04422379 — COVID-19 and Liver Injury in Patients With or Without Underlying Liver Disease: A Multi-centre Retrospective-prospective · unknown
NCT04469660 — Impact of COVID-19 Pandemic on the Psychological Wellbeing of Healthcare Professionals in India · unknown
NCT04374487 — Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications · Phase 2 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04406844 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Max Healthcare Insititute Limited
Last refreshed: 22 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04406844.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing